CSL Behring
nationwide
The Opportunity Building on the success of our recent US approval for HEMGENIX® (etranacogene dezaparvovec-drlb), the world's first gene therapy for hemophilia B, you will join a lean but growing team committed to bringing new gene therapies to patients. As a successful Senior Lead Fill & Finish Gene Therapy, you ensure cross-site, cross-value stream, and intercompany tech and knowledge transfer for the area of Fill & Finish of Gene Therapy Molecules across projects. You deliver and contribute to the robustness of the process, design of process equipment, technology transfer, technology selection for manufacturing, and PAT systems. Work onsite in the greater Boston, Massachusetts area is required. The Role Champion transformation of process engineering, manufacturing technologies & innovation at CSL. Contribute to and lead the Fill & Finish aspects of the tech transfer of products to alternate sites including CMOs Support site-specific Root Cause Analysis...